# Elkhalili, Abdelnaser MD – FDA Inspection, May 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/elkhalili-abdelnaser-md/6cc12fa6-a53b-4649-b4bc-f433a4f4f822
Source feed: FDA_Inspections

> FDA inspection 1051826 of Elkhalili, Abdelnaser MD, May 14, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051826
- Company Name: Elkhalili, Abdelnaser MD
- Inspection Date: 2018-05-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/anya-d-lockett-evans/afddc255-78ab-472c-9a69-f4cb9967f180)

Company: https://www.keypedia.com/companies/elkhalili-abdelnaser-md/5b982192-54d0-4ea3-ad4d-c85d72e56fde

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c